You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Esophagogastric Junction Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Novel Staging Schemes for Siewert Type II Esophagogastric

Completed
  • Adenocarcinoma of the Esophagogastric Junction
  • esophagogastric junction cancer surgery
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Nov 1, 2022

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Epiphora Due to Insufficient Drainage, Left Side, Epiphora Due to Insufficient Drainage, Right Side Trial in Tianjin

Recruiting
  • Epiphora Due to Insufficient Drainage, Left Side
  • Epiphora Due to Insufficient Drainage, Right Side
  • Esophagogastric Side to Side Anastomosis
  • Esophagogastric End to Side Anastomosis
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Apr 2, 2023

Esophagus Cancer Trial in Loma Linda (Proton radiation)

Recruiting
  • Esophagus Cancer
  • Proton radiation
  • Loma Linda, California
    Loma Linda University Medical Center
Feb 16, 2022

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Lexington (drug, radiation, procedure)

Not yet recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Intravenous Tislelizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Feb 21, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Neoadjuvant Chemotherapy and Immunotherapy for HER2(-),pMMR

Recruiting
  • Gastric Cancer
  • SOX plus Paclitaxel(albumin-bound) followed by PD-1 antibody
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 12, 2022

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

Advanced Solid Tumors, Gastric Cancer, Esophagogastric Junction Cancer Trial in Beijing (IM92 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM92 CAR-T cells
  • Beijing, Beijing, China
    Chinese PLA GENERAL HOSPITAL
Mar 10, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Esophagogastric Junction Adenocarcinoma Trial in Guangzhou (Sintilimab)

Recruiting
  • Esophagogastric Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 29, 2021

Toripalimab Combined With Anlotinib for Advanced, Relapsed, or

Recruiting
  • Gastric or Gastro-oesophageal Junction Carcinoma
  • +2 more
  • FGFR2
  • Qingdao, China
    Xiaochun Zhang
Jun 29, 2021

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022

Gastric Cancer, Esophagogastric Junction Disorder Trial in Beijing (Savolitinib)

Recruiting
  • Gastric Cancer
  • Esophagogastric Junction Disorder
  • Beijing, Beijing, China
    Beijing Cancer Hopspital
Aug 30, 2021

CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

Recruiting
  • CAR T-Cell Therapy
  • HEC-016(0.5×10^6 CAR-T Cells)
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Luohu Hospital
Mar 3, 2022

Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Surgery
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

Recruiting
  • Esophagogastric Tumors
  • +9 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 8, 2022

Gastric Cancer Trial in Beijing (Radical gastrectomy with dissection of lower mediastinal lymph node)

Recruiting
  • Gastric Cancer
  • Radical gastrectomy with dissection of lower mediastinal lymph node
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 21, 2021

Stomach Tumor, Gastrointestinal Tumors, Digestive System Tumor Trial in Havana (Ocoxin-Viusid®)

Recruiting
  • Stomach Neoplasm
  • +9 more
  • Ocoxin-Viusid®
  • Havana, La Habana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Oct 20, 2021

Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • Oxaliplatin; Capecitabine
  • Oxaliplatin; Capecitabine; concurrent radiotherapy
  • Shijiazhuang, Hebei, China
    Department of General Surgery
Feb 4, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Gastric Tumor, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Dresden, Heidelberg (Biopsy)

Active, not recruiting
  • Gastric Neoplasm
  • +4 more
  • Biopsy
  • Dresden, Germany
  • +1 more
Feb 22, 2022

Gastric Adenocarcinoma, Gastric Cancer, Esophagogastric Junction Trial run by the NCI (Paclitaxel, Capecitabine, BardPort

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Gastric Cancer Trial in Frankfurt am Main (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Feb 21, 2022